Marta O. Freitas

723 citations
12 papers · 552 indexed · h-index 12
Topics
Peroxisome Proliferator-Activated Receptors (5 papers)RNA Research and Splicing (5 papers)RNA modifications and cancer (2 papers)

In The Last Decade

Marta O. Freitas

12 papers receiving 549 citations

Peers

Marta O. Freitas
Comparison fields: 5 of 63
  • Molecular Biology 441
  • Immunology 90
  • Cancer Research 74
  • Epidemiology 37
  • Physiology 37
Replace Jason A. Lehman with:
Jason A. Lehman United States
Nathiya Muthalagu United Kingdom
Lilian Stärck Germany
Yunkyung Heo South Korea
Kerstin Brinkmann Germany
Sue-Chin Lee United States
Jung Yoo South Korea
Maria Plana Spain
Duran Sürün Germany
Weei-Chin Lin United States
Marta O. Freitas relative to Jason A. Lehman United States Jason A. Lehman's profile →
Citations per field
00.5×4.2×
Jason A. Lehman · 1×
Citations per year

Countries citing papers authored by Marta O. Freitas

Since Specialization
Citations

This map shows the geographic impact of Marta O. Freitas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta O. Freitas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta O. Freitas more than expected).

Fields of papers citing papers by Marta O. Freitas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta O. Freitas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta O. Freitas. The network helps show where Marta O. Freitas may publish in the future.

Co-authorship network of co-authors of Marta O. Freitas

This figure shows the co-authorship network connecting the top 25 collaborators of Marta O. Freitas. A scholar is included among the top collaborators of Marta O. Freitas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta O. Freitas. Marta O. Freitas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 19
2 31
3 27
4 16
5 24
6 46
7 31
8 43
9 81
10 77
11 105
12 52

About Marta O. Freitas

Marta O. Freitas is a scholar working on Hematology, Clinical Biochemistry and Immunology, having authored 12 papers that have together received 552 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (5 papers), RNA Research and Splicing (5 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Molecular Biology (441 citations), Cancer Research (74 citations) and Immunology (90 citations). Marta O. Freitas has collaborated with scholars based in United Kingdom, Portugal and Belgium. Frequent co-authors include Cláudia P. Grou, Jorge E. Azevedo, Tânia Francisco, Tony A. Rodrigues, Manuel P. Pinto, Andreia F. Carvalho, Clara Sá-Miranda, Marc Fransen, Kieron South and David A. Lane. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026